Perritt Capital Management’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
KGAMU
6CM
Perritt Capital Management's CDLX Position: Q3 2020 in Review
Perritt Capital Management sold out of Cardlytics (CDLX) in Q3 2020, closing a stake of 400 shares — an estimated $280K sold.
Perritt Capital Management first reported a position in CDLX in Q1 2019 and held it in 6 quarters. The position peaked at $949K in Q4 2019. 164 funds tracked by Wall St. Rank hold CDLX as of Q3 2020.
- Perritt Capital Management reported no remaining Cardlytics position as of Q3 2020 after selling out during the quarter.
- Perritt Capital Management sold 400 Cardlytics shares in Q3 2020, an estimated $280K.
- Perritt Capital Management first reported a position in Cardlytics in Q1 2019 and held it in 6 quarters.
- Perritt Capital Management's Cardlytics position peaked at $949K in Q4 2019.
- 164 funds tracked by Wall St. Rank held Cardlytics as of Q3 2020.
Based on Perritt Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.